片仔癀股价微跌0.5% 人事调整与业绩压力引关注

Group 1 - The stock price of Pian Zai Huang is reported at 200.93 yuan, down 0.50% from the previous trading day, with an intraday fluctuation of 0.91% and a trading volume of 590 million yuan [1] - Pian Zai Huang operates in the traditional Chinese medicine industry, focusing on the production and sales of traditional Chinese patent medicines, with its core products including the Pian Zai Huang series [1] - On August 14, the company announced personnel changes, appointing He Wei as the deputy general manager and Wei Tengyun as the chief engineer, following the resignation of board member Lai Wenning and supervisor Huang Qiumin [1] Group 2 - In Q1 2025, the company's revenue decreased by 0.92% year-on-year, while net profit increased by 2.59% year-on-year [1] - The revenue growth rate for the entire year of 2024 reached a ten-year low, with core product prices significantly declining from their peak in 2021 [1] - On August 15, the net inflow of main funds was 35.47 million yuan, with a cumulative net inflow of 65.68 million yuan over the past five days [1]